Tag : Biogen

Latest News

Streamlining Immuno-Oncological Therapeutic Antibody Discovery

Newsemia
The growing trend of implementing immunotherapy into oncology has resulted in various new therapeutic cancer treatments utilizing antibodies. Source link...
Neurology

Researchers identify genes linked to most severe symptoms of multiple sclerosis

Newsemia
In a bid to determine factors linked to the most debilitating forms of multiple sclerosis, Johns Hopkins Medicine researchers say they have identified three so-called...
Latest News

Biogen and Eisai present detailed results from phase 1b study of aducanumab at CTAD meeting

Newsemia
Biogen and Eisai Co., Ltd. announced that Biogen presented results at the Clinical Trials on Alzheimer’s Disease meeting, in Barcelona, Spain, from the recent 36-...
Latest News

Anti-Lymphotoxin – Pipeline Insight Report 2018 Featuring Roche, Zydus, Amgen & Biogen Idec – ResearchAndMarkets.com

Newsemia
DUBLIN–(BUSINESS WIRE)–The “Anti-Lymphotoxin -Pipeline Insight, 2018” drug pipelines has been added to ResearchAndMarkets.com’s offering. ‘Anti-Lymphotoxin – Pipeline Insight, 2018’ report offers comprehensive insights of the...
Latest News

Alternative method identified for delivering nusinersen to spinal muscular atrophy patients

Newsemia
A new report has identified an alternative method to deliver nusinersen to patients with spinal muscular atrophy using a subcutaneous intrathecal catheter system configured by...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy